Related Experiment Videos
Can we prevent or treat renal dysfunction in chronic heart failure?
Daniela Dobre1, Patrick Rossignol, Marco Metra
1INSERM, Center of Clinical Investigation-9501, University Hospital Nancy, Lorrain Institute of Heart and Vessels Louis Mathieu, 4, rue du Morvan, 54500 Vandoeuvre-les-Nancy, France. d.dobre@chu-nancy.fr
Heart Failure Reviews
|June 23, 2011
Summary
Predictors of renal dysfunction in chronic heart failure (CHF) include age, comorbidities, and certain medications. Prevention is possible through managing these factors, but specific treatments for kidney dysfunction in CHF are still under investigation.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Chronic Heart Failure (CHF) is frequently associated with renal dysfunction.
- Kidney impairment significantly worsens prognosis and complicates CHF management.
Purpose of the Study:
- To identify key predictors of renal dysfunction in patients with CHF.
- To outline current strategies for preventing and managing renal dysfunction in CHF.
- To review the status of potential treatments for renal dysfunction in this population.
Main Methods:
- Literature review and synthesis of existing studies on renal dysfunction in CHF.
- Analysis of factors contributing to renal impairment in heart failure patients.
- Evaluation of preventive and therapeutic approaches.
Main Results:
- Predictors of renal dysfunction in CHF include advanced age, comorbidities (anemia, hypertension, diabetes), heart disease severity (systolic/diastolic dysfunction, elevated central venous pressure), and specific medications (diuretics, NSAIDs, RAAS inhibitors).
- Prevention strategies involve managing comorbidities, optimizing heart failure treatment, and careful monitoring of potentially nephrotoxic therapies.
- Currently, no specific treatment exists for renal dysfunction in CHF, although novel therapeutic agents are under investigation.
Conclusions:
- Renal dysfunction in CHF is multifactorial, with identifiable predictors.
- Preventive measures are crucial and achievable in CHF patients.
- Effective treatments for established renal dysfunction in CHF are lacking and require further research.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...